Dermatophagoides farinae allergens (Der f allergens) (Der f allergens)

Dermatophagoides farinae allergens are a group of proteins derived from the American house dust mite that serve as primary triggers for IgE-mediated allergic diseases in sensitized individuals (Source: WHO/IUIS Allergen Nomenclature). The most clinically significant components include Der f 1, a cysteine protease that can disrupt epithelial tight junctions, and Der f 2, a lipid-binding protein that facilitates TLR4 signaling by mimicking MD-2 (Source: PMID: 25108386). These allergens interact with the human immune system by cross-linking allergen-specific IgE on the surface of mast cells and basophils, leading to the release of inflammatory mediators such as histamine and leukotrienes (Source: StatPearls, Type I Hypersensitivity). In a therapeutic context, these allergens are the active components of allergen immunotherapy (AIT), such as the FDA-approved sublingual tablet Odactra, which is designed to induce long-term clinical tolerance (Source: FDA Odactra Prescribing Information). AIT works by shifting the immune response from a Th2-dominated allergic profile to a Treg-mediated suppressive state, providing relief for conditions like allergic rhinitis and asthma (Source: PMID: 30103933).

Other names

American house dust mite allergensDer f allergensHouse dust mite allergens

Allergen immunotherapy (AIT) involves the repeated administration of specific allergens to induce immunological tolerance, characterized by the induction of regulatory T cells, a shift from Th2 to Th1 cytokine profiles, and the production of allergen-specific IgG4 antibodies that block IgE-mediated mast cell degranulation (Source: PMID: 30103933).